Voltage-gated calcium channels and pain

Pain

Volumn 126, Issue 1-3, 2006, Pages 5-9

  Cao, Yu Qing ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AM 336; CALCIUM CHANNEL; CALCIUM CHANNEL ALPHA2DELTA SUBUNIT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL PQ TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; G PROTEIN COUPLED RECEPTOR; GABAPENTIN; MORPHINE; NMED 160; OMEGA CONOTOXIN MVIIA; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

CANCER PAIN; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHANNEL GATING; HUMAN; HYPERALGESIA; INTERNALIZATION; MEMBRANE CHANNEL; NERVE INJURY; NEUROMODULATION; NEUROPATHIC PAIN; NEUROTOXICITY; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD NERVE CELL; SPINAL GANGLION; TISSUE INJURY;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, N-TYPE; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CALCIUM CHANNELS, T-TYPE; HUMANS; PAIN; PROTEIN ISOFORMS;

EID: 33751019450     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.10.019     Document Type: Review

References (36)

1. Adams D.J., Smith A.B., Schroeder C.I., Yasuda T., and Lewis R.J. Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J Biol Chem 278 (2003) 4057-4062
2. Altier C., Khosravani H., Evans R.M., Hameed S., Peloquin J.B., Vartian B.A., et al. ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci 9 (2006) 31-40
3. Ayata C., Shimizu-Sasamata M., Lo E.H., Noebels J.L., and Moskowitz M.A. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels. Neuroscience 95 (2000) 639-645
4. Bell T.J., Thaler C., Castiglioni A.J., Helton T.D., and Lipscombe D. Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 41 (2004) 127-138
5. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., and Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8 (2002) 136-142
6. Bourinet E., Alloui A., Monteil A., Barrere C., Couette B., Poirot O., et al. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24 (2005) 315-324
7. 2+ channel activity and inhibitory synaptic transmission. Proc Natl Acad Sci USA 102 (2005) 2590-2595
8. 2+ channelopathy. Neuron 43 (2004) 387-400
9. 2+ channels. Annu Rev Cell Dev Biol 16 (2000) 521-555
10. Ebersberger A., Portz S., Meissner W., Schaible H.G., and Richter F. Effects of N-, P/Q- and L-type calcium channel blockers on nociceptive neurones of the trigeminal nucleus with input from the dura. Cephalalgia 24 (2004) 250-261
11. 2+ channels. Science 302 (2003) 117-119
12. Knight Y.E., Bartsch T., Kaube H., and Goadsby P.J. P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine?. J Neurosci 22 (2002) 1-6
13. Luvisetto S., Marinelli S., Panasiti M.S., D'Amato F.R., Fletcher C.F., Pavone F., et al. Pain sensitivity in mice lacking the Ca(v)2.1alpha(1) subunit of P/Q-type Ca(2+) channels. Neuroscience 142 (2006) 823-832
14. Matthews E.A., and Dickenson A.H. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 92 (2001) 235-246
15. Matthews E.A., and Dickenson A.H. A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. Anesthesiology 96 (2002) 633-640
16. McGivern J.G., and McDonough S.I. Voltage-gated calcium channels as targets for the treatment of chronic pain. Curr Drug Targets CNS Neurol Disord 3 (2004) 457-478
17. Miljanich G.P. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem 11 (2004) 3029-3040
18. Nelson M.T., Todorovic S.M., and Perez-Reyes E. The role of T-type calcium channels in epilepsy and pain. Curr Pharm Des 12 (2006) 2189-2197
19. Nowycky M.C., Fox A.P., and Tsien R.W. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316 (1985) 440-443
20. 2+ channel mutant mice, leaner. FEBS Lett 508 (2001) 181-186
21. Olivera B.M., Miljanich G.P., Ramachandran J., and Adams M.E. Calcium channel diversity and neurotransmitter release: the ω-Conotoxins and ω-Agatoxins. Annu Rev Biochem 63 (1994) 823-867
22. 2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
23. Pietrobon D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr Opin Neurobiol 15 (2005) 257-265
24. Saegusa H., Matsuda Y., and Tanabe T. Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. Neurosci Res 43 (2002) 1-7
25. Snutch T.P. Targeting chronic and neuropathic pain: the N-type calcium channel comes of age. NeuroRx 2 (2005) 662-670
26. Takahashi T., and Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature 366 (1993) 156-158
27. Taylor C.P. The biology and pharmacology of calcium channel alpha2-delta proteins Pfizer Satellite Symposium to the 2003 Society for Neuroscience Meeting. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003. CNS Drug Rev 10 (2004) 183-188
28. Tombler E., Cabanilla N.J., Carman P., Permaul N., Hall J.J., Richman R.W., et al. G protein-induced trafficking of voltage-dependent calcium channels. J Biol Chem 281 (2006) 1827-1839
29. Tottene A., Fellin T., Pagnutti S., Luvisetto S., Striessnig J., Fletcher C., et al. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA 99 (2002) 13284-13289
30. Tsien R.W., and Wheeler D.B. Voltage-gated calcium channels. In: Carafoli E., and Klee C.B. (Eds). Calcium as a cellular regulator (1999), Oxford University Press, New York 171-199
31. Van Den Maagdenberg A.M., Pietrobon D., Pizzorusso T., Kaja S., Broos L.A., Cesetti T., et al. A cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41 (2004) 701-710
32. Vanegas H., and Schaible H. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 85 (2000) 9-18
33. 2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci 18 (1998) 6319-6330
34. Wu Z.Z., Chen S.R., and Pan H.L. Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calcium-dependent calcineurin in sensory neurons. J Biol Chem 280 (2005) 18142-18151
35. Yaksh T.L. Calcium channels as therapeutic targets in neuropathic pain. J Pain 7 (2006) S13-S30
36. 2+ channel-mutant mouse, tottering. J Physiol 547 (2003) 497-507